Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Army
Boehringer Ingelheim
Citi
Cerilliant
Express Scripts
US Department of Justice
Chubb
UBS

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021528

« Back to Dashboard

NDA 021528 describes ACULAR LS, which is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ACULAR LS profile page.

The generic ingredient in ACULAR LS is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
Summary for 021528
Tradename:ACULAR LS
Applicant:Allergan
Ingredient:ketorolac tromethamine
Patents:8
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021528
Medical Subject Heading (MeSH) Categories for 021528
Suppliers and Packaging for NDA: 021528
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACULAR LS ketorolac tromethamine SOLUTION/DROPS;OPHTHALMIC 021528 NDA Allergan, Inc. 0023-9277 N 0023-9277-05
ACULAR LS ketorolac tromethamine SOLUTION/DROPS;OPHTHALMIC 021528 NDA AUTHORIZED GENERIC Physicians Total Care, Inc. 54868-6416 E 54868-6416-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.4%
Approval Date:May 30, 2003TE:ATRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 24, 2027Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Nov 28, 2024Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Nov 28, 2024Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Accenture
Daiichi Sankyo
Citi
McKinsey
Deloitte
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.